Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEach dose of Mounjaro is 0.5 ml, regardless of which strength you are taking. The volume stays fixed across every pen from 2.5 mg right up to 15 mg; what changes is the concentration of tirzepatide dissolved in that half-millilitre. This is a prescription-only medicine — a clinician assesses your full picture before any treatment begins, and the dose you start on is chosen for you specifically.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture a very small syringe, 0.5 ml fills roughly a tenth of a teaspoon. That is what the Mounjaro KwikPen delivers every week, and it is the same amount whether you are on the starting 2.5 mg pen or the highest 15 mg pen. The pen does all the measuring for you. There is no dial to set, no plunger to draw back. You press the KwikPen against your skin, press the button, and the device releases exactly 0.5 ml.
The Mounjaro overview covers the full picture of how tirzepatide works, but on the volume question specifically: the number that changes between pens is the concentration. A 2.5 mg pen contains 2.5 mg of tirzepatide dissolved in 2 ml of solution (giving 1.25 mg per ml); a 15 mg pen contains 15 mg in the same 2 ml (7.5 mg per ml). Four doses of 0.5 ml, four weeks of treatment, one pen. The Mounjaro SmPC on the electronic Medicines Compendium sets out the exact pharmaceutical specifications if you want to read the primary source.
Why does this matter practically? If you ever need to cross-reference the volume in the context of storage or travel, knowing it is always 0.5 ml helps. It also explains why the pen looks the same size regardless of strength, the liquid quantity is identical; only its potency differs. For anything beyond the volume figure, including what to do after each dose, guidance on what happens with the pen after each dose is worth reading before your first injection.
The first pen most people use is the 2.5 mg strength. Its job is not to produce significant weight loss; it exists to let your system settle into the medicine at the gentlest possible concentration. The 0.5 ml you inject in week one contains exactly the same liquid volume as the 0.5 ml you would inject in week forty-eight on 15 mg, but the biological effect is far smaller, which is the point.
Nausea, the most common early side effect, tends to be milder when the body is introduced to tirzepatide gradually. More detail on the 2.5 mg volume and what it contains is available if you want to go deeper on that starting strength specifically. After roughly four weeks, a prescriber will assess whether moving to the next strength is appropriate. That assessment matters, it is not automatic.
One practical detail worth knowing: the pen lives in the fridge, ideally somewhere you will see it at eye level rather than buried at the back. A consistent weekly habit, same time and day, makes the titration schedule easier to follow. Your prescriber and the Patient Information Leaflet will confirm the exact storage window that applies, since room-temperature rules vary and the leaflet is the definitive reference.
No, the volume is constant. Every strength of Mounjaro delivers 0.5 ml. For anyone who has looked up this question because they spotted a different figure somewhere online, it is worth checking the source carefully. The consistent 0.5 ml delivery is confirmed in the Mounjaro prescribing information and is one of the product's design features, not an approximation.
For those who want to work through the arithmetic by strength, the 5 mg pen's volume and concentration is covered separately, and the 5 mg Mounjaro page covers the broader context of that dose. The logic is the same across the range: ml stays at 0.5, milligrams go up. There is also a common question about whether the volume per dose is different from what some older sources stated, it is not; the KwikPen has always been designed around 0.5 ml injections.
The NHS patient information for tirzepatide at nhs.uk/medicines/tirzepatide is a reliable starting point for side effects, how to inject, and what to watch for. If you are looking at the cost of treatment across strengths, the Mounjaro cost guide puts private pricing in context without the noise.
One thing that catches people out: because the injection always looks and feels the same size, the increase in dose can feel abstract. You are not injecting more liquid, you are injecting a more concentrated version of the same liquid. For patients who are anxious about injections, this is actually reassuring; the physical experience at 15 mg is not more uncomfortable than at 2.5 mg by virtue of volume.
There is a separate question about how many ml are in a full Mounjaro pen overall, which is 2 ml total across the four doses. A dedicated breakdown of the per-dose ml figure goes through this in detail, and this related page looks at how that volume fits within the pen's total. Both are straightforwardly factual reads.
If you have questions specific to your own treatment (about titration timing, switching strengths, or how the volume figures apply to your situation) those are conversations for a prescriber rather than a product page. At nume, a GPhC-registered Independent Prescriber reads every consultation personally. Speak to our prescribers through a free consultation if you are considering treatment or have questions before you start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.